Midodrine helps cirrhotic patients live longer, data show

08/8/2011 | Medscape (free registration)

Long-term treatment with midodrine in addition to standard medical care increased survival and improved ascites control for cirrhotic patients in a pilot study of 40 patients reported in the Journal of Hepatology. Patients in the treatment group had increases in average arterial pressure, urinary volume and urine sodium excretion, and demonstrated a drop in plasma renin activity and plasma aldosterone concentrations.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR